Suppr超能文献

一般肿瘤 PET/CT 人群中肿瘤活性的定量评估:哪种指标可最大限度减少示踪剂摄取时间依赖性?

Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?

机构信息

Department of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Siemens Medical Solutions Inc., Knoxville, Tennessee; and.

出版信息

J Nucl Med. 2024 Sep 3;65(9):1349-1356. doi: 10.2967/jnumed.123.266469.

Abstract

In oncologic PET, the SUV and standardized uptake ratio (SUR) of a viable tumor generally increase during the postinjection period. In contrast, the net influx rate ( ), which is derived from dynamic PET data, should remain relatively constant. Uptake-time-corrected SUV (cSUV) and SUR (cSUR) have been proposed as uptake-time-independent, static alternatives to Our primary aim was to quantify the intrascan repeatability of , SUV, cSUV, SUR, and cSUR among malignant lesions on PET/CT. An exploratory aim was to assess the ability of cSUR to estimate This prospective, single-center study enrolled adults undergoing standard-of-care oncologic PET/CT. SUV and images were reconstructed from dynamic PET data obtained before (∼35-50 min after injection) and after (∼75-90 min after injection) standard-of-care imaging. Tumors were manually segmented. Quantitative metrics were extracted. cSUVs and cSURs were calculated for a 60-min postinjection reference uptake time. The magnitude of the intrascan test-retest percent change (test-retest |%Δ|) was calculated. Coefficients of determination ( ) and intraclass correlation coefficients (ICC) were also computed. Differences between metrics were assessed via the Wilcoxon signed-rank test (α, 0.05). This study enrolled 78 subjects; 41 subjects (mean age, 63.8 y; 24 men) with 116 lesions were analyzed. For both tracers, SUV and maximum SUR (SUR) had large early-to-late increases (i.e., poor intrascan repeatability). Among [F]FDG-avid lesions ( = 93), there were no differences in intrascan repeatability (median test-retest |%Δ|; ICC) between the maximum ( ) (13%; 0.97) and either the maximum cSUV (cSUV) (12%, = 0.90; 0.96) or the maximum cSUR (cSUR) (13%, = 0.67; 0.94). For DOTATATE-avid lesions ( = 23), there were no differences in intrascan repeatability between the (11%; 0.98) and either the cSUV (13%, = 0.41; 0.98) or the cSUR (11%, = 0.08; 0.94). The SUV, cSUV, SUR, and cSUR were all strongly correlated with the for both [F]FDG ( , 0.81-0.92) and DOTATATE ( , 0.88-0.96), but the cSUR provided the best agreement with the across early-to-late time points for [F]FDG (ICC, 0.69-0.75) and DOTATATE (ICC, 0.90-0.91). , cSUV, and cSUR had low uptake time dependence compared with SUV and SUR The can be predicted from cSUR.

摘要

在肿瘤学 PET 中,有活力的肿瘤的 SUV 和标准化摄取比值(SUR)通常在注射后期间增加。相比之下,净摄入率(),它是从动态 PET 数据中得出的,应该保持相对稳定。已提出摄取时间校正的 SUV(cSUV)和 SUR(cSUR)作为摄取时间独立的静态替代物来替代。我们的主要目的是量化恶性病变的 PET/CT 中摄取时间校正的 SUV、cSUV、SUR 和 cSUR 的扫描内重复性。探索性的目的是评估 cSUR 估计的能力。这项前瞻性的单中心研究纳入了接受标准护理肿瘤学 PET/CT 的成年人。SUV 和图像是从动态 PET 数据重建的,这些数据是在(注射后约 35-50 分钟)和标准护理成像后(注射后约 75-90 分钟)获得的。肿瘤手动分割。提取定量指标。对于 60 分钟的注射后参考摄取时间计算 cSUV 和 cSUR。计算扫描内测试-再测试的百分比变化的幅度(测试-再测试|%Δ|)。还计算了决定系数()和组内相关系数(ICC)。通过 Wilcoxon 符号秩检验(α,0.05)评估指标之间的差异。这项研究纳入了 78 名受试者;41 名受试者(平均年龄 63.8 岁;24 名男性)有 116 个病变进行了分析。对于两种示踪剂,SUV 和最大 SUR(SUR)都有早期到晚期的大幅增加(即扫描内重复性差)。在[F]FDG-avid 病变中(=93),最大和之间的扫描内重复性(中位数测试-再测试|%Δ|;ICC)没有差异()(13%,=0.97;0.96)或最大 cSUV(cSUV)(12%,=0.90;0.90)或最大 cSUR(cSUR)(13%,=0.67;0.94)。在 DOTATATE-avid 病变中(=23),最大和之间的扫描内重复性没有差异(11%,=0.98;0.98)或 cSUV(13%,=0.41;0.98)或 cSUR(11%,=0.08;0.94)。SUV、cSUV、SUR 和 cSUR 与和之间均有很强的相关性,对于[F]FDG(,0.81-0.92)和 DOTATATE(,0.88-0.96),但 cSUR 在[F]FDG 的早期到晚期时间点提供了与之间的最佳一致性(ICC,0.69-0.75)和 DOTATATE(ICC,0.90-0.91)。与 SUV 和 SUR 相比,摄取时间校正的 SUV、cSUV 和 cSUR 的摄取时间依赖性较低。从 cSUR 可以预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49bc/11372261/e89da29f35e2/jnumed.123.266469absf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验